SEXUAL WELLNESS & PIGMENTATION
Melanotan II
Cyclic alpha-MSH analog. Studied in melanocortin-receptor and pigmentation research.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99.2%
purity
✓ Passed full QC panel
- Variant
- Melanotan II · 10 mg
- Lot #
- AML-2026-0530
- Labeled
- 10 mg
- Tested
- 2026-04-28
Full QC panel
- Purity (HPLC)
- 99.2%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 121062-08-6
- Molecular Formula
- C50H69N15O9
- Molecular Weight
- 1024.2 g/mol
- Sequence
- Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
- Type
- Research peptide
- PubChem
- CID 92432 ↗
Biological targets
Interactions
- Primary target
- Melanocortin receptors (MC1R, MC3R, MC4R, MC5R)
- Pathway
- MC1R–cAMP melanogenesis; MC4R central signaling
- Mechanism
- Cyclic non-selective melanocortin agonist
- Research area
- Pigmentation and melanocortin-system research
Physical properties
Handling & Storage
- Appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
CEN CASE REPORTS
Melanotan II: a possible cause of renal infarction: review of the literature and case report
2020 · PMID 31953620
Peters B et al.
View Source ↗DERMATOLOGY (BASEL, SWITZERLAND)
Melanotan II User Experience: A Qualitative Study of Online Discussion Forums
2021 · PMID 34464955
Gilhooley E et al.
View Source ↗DERMATOLOGY (BASEL, SWITZERLAND)
Melanoma associated with the use of melanotan-II
2014 · PMID 24355990
Hjuler KF et al.
View Source ↗DRUG TESTING AND ANALYSIS
LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs
2021 · PMID 33245851
Mestria S et al.
View Source ↗LIFE SCIENCES
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
1996 · PMID 8637402
Dorr RT et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.